Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, featuring promising improvements throughout numerous healthcare and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA offers a safer, much more dependable alternative for therapeutic